AstraZeneca Q3 Profit Declines; Raises FY Product Sales Growth Outlook

British drug major AstraZeneca (AZN.L, AZN) reported Thursday that its third-quarter profit before tax declined 14 percent to $409 million from last year's $477 million.

from RTT - Earnings https://ift.tt/2PivbrB
via IFTTT